Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By boosting these receptors, https://karimdugy646961.angelinsblog.com/35229331/tirzepatide-a-promising-new-treatment-for-obesity